Context Therapeutics Inc. · NASDAQ:CNTX

Mpm Bioimpact LLC reported a 11.60% stake in Context Therapeutics Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Mpm Bioimpact LLC reported a 11.60% stake in Context Therapeutics Inc., 10,679,391 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
11.60%
Shares
10,679,391
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
MPM BioImpact LLC11.60%10,679,391

Source

View original at SEC

Related